Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study

BACKGROUND: Direct oral anticoagulants (DOACs) are not only increasingly being used for the initial stroke prevention therapy but progressively also substitute vitamin K antagonist (VKA) treatment in patients with non-valvular atrial fibrillation (AF). DOACs have been compared regarding therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Paschke, Lena M., Klimke, Kerstin, Altiner, Attila, von Stillfried, Dominik, Schulz, Maike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450597/
https://www.ncbi.nlm.nih.gov/pubmed/32847578
http://dx.doi.org/10.1186/s12916-020-01695-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450597/
https://www.ncbi.nlm.nih.gov/pubmed/32847578
http://dx.doi.org/10.1186/s12916-020-01695-7

Ejemplares similares